Immunai
Sen Zhang, Immunai’s Vice President of Product, joined Immunai in January 2020. Prior to Immunai, Sen spent a decade leading a variety of product and business initiatives at Two Sigma Investments, Flatiron Health, and Palantir Technologies. Sen started his career as a consultant at Oliver Wyman, working on a variety of projects in the financial services industry.
Sen earned BAs in Biology and Economics at Dartmouth College.
Immunai
2 followers
Immunai is comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes.